as soon as is submitted to ZB.
Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine.
Nat. Rev. Gastroenterol. Hepatol. 22, 226–227 (2025)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous disease regarding its pathophysiology and clinical outcomes. Two novel studies suggest that different clusters of people with MASLD exist, explaining part of this heterogeneity. These findings and future research applying data dimensionality reduction approaches might be beneficial for implementing precision medicine in MASLD.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Other: News Item
ISSN (print) / ISBN
1759-5045
e-ISSN
1759-5053
Quellenangaben
Volume: 22,
Pages: 226–227
Publisher
Nature Publishing Group
Publishing Place
Heidelberger Platz 3, Berlin, 14197, Germany
Reviewing status
Peer reviewed
Grants
European Innovative Medicines Initiative SOPHIA
German Center of Diabetes Research (DZD)
German Federal Ministry of Education and Research (BMBF)
German Center of Diabetes Research (DZD)
German Federal Ministry of Education and Research (BMBF)